ArticleImmunity & ageing : I & A2022

Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine.

Chalerm Liwsrisakun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.